Ezh2 GOF was enacted using the ColA1-LSL-Ezh2Y646N allele (Béguelin et al., 2013), which allows conditional Ezh2Y646N expression upon Cre recombination and suffices for melanoma initiation upon MAPK activation (Zingg et al., 2018). This evidence concerns the gene EZH2 and melanoma.